Mimedx (MDXG) Free Cash Flow Growth (3y) (2014 - 2026)
Mimedx (MDXG) Free Cash Flow Growth (3y) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
24.91% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
20.11% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
14.71% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Mimedx |
546.28 Mn |
386.51 Mn |
41.62 Mn |
31.61% |
| Date | Value |
|---|
| Mar 31, 2026 |
31.61% |
| Dec 31, 2025 |
89.42% |
| Sep 30, 2025 |
262.83% |
| Jun 30, 2025 |
83.78% |
| Mar 31, 2025 |
35.28% |
| Dec 31, 2024 |
54.65% |
| Sep 30, 2024 |
47.41% |
| Jun 30, 2024 |
166.66% |
| Mar 31, 2024 |
36.81% |
| Dec 31, 2023 |
38.66% |
| Sep 30, 2023 |
66.36% |
| Jun 30, 2023 |
60.46% |
| Mar 31, 2023 |
29.38% |
| Dec 31, 2022 |
29.11% |
| Sep 30, 2022 |
29.74% |
| Jun 30, 2022 |
-56.07% |
| Mar 31, 2022 |
13.37% |
| Dec 31, 2021 |
-238.57% |
| Sep 30, 2021 |
62.49% |
| Jun 30, 2021 |
-59.68% |
